Margus Viigimaa
Overview
Explore the profile of Margus Viigimaa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
83
Citations
9138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elshorbagy A, Vallejo-Vaz A, Barkas F, Lyons A, Stevens C, Dharmayat K, et al.
Eur Heart J
. 2025 Jan;
PMID: 39801189
Background And Aims: Overweight and obesity are modifiable risk factors for atherosclerotic cardiovascular disease (ASCVD) in the general population, but their prevalence in individuals with heterozygous familial hypercholesterolaemia (HeFH) and...
2.
Banach M, Reiner Z, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, et al.
Drugs
. 2024 Nov;
84(12):1541-1577.
PMID: 39497020
Atherosclerotic cardiovascular disease (ASCVD) and consequent acute coronary syndromes (ACS) are substantial contributors to morbidity and mortality across Europe. Fortunately, as much as two thirds of this disease's burden is...
3.
Talviste G, Leinsalu M, Ross P, Viigimaa M
Medicina (Kaunas)
. 2024 Sep;
60(9).
PMID: 39336474
Patients with previous acute myocardial infarction are at significantly higher risk of recurrent events. Early and intensive lipid-lowering therapy targeting low-density lipoprotein cholesterol is a key strategy for reducing cardiovascular...
4.
Halimi J, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, et al.
Blood Press
. 2024 Jun;
33(1):2368800.
PMID: 38910347
Objective Real-life management of patients with hypertension and chronic kidney disease (CKD) among European Society of Hypertension Excellence Centres (ESH-ECs) is unclear : we aimed to investigate it. Methods A...
5.
Halimi J, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, et al.
J Hypertens
. 2024 May;
42(9):1544-1554.
PMID: 38747416
Objective: Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear. Methods: A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management...
6.
Weber T, Doumas M, Delles C, Jelakovic B, Viigimaa M, Narkiewicz K, et al.
Blood Press
. 2023 Oct;
32(1):2269431.
PMID: 37837345
Purpose: To describe the history of the Excellence Centre (EC) programme of the European Society of Hypertension (ESH) since the beginning in 2006, its achievements, and its future developments. Materials...
7.
Viigimaa M, Jurisson M, Pisarev H, Kalda R, Alavere H, Irs A, et al.
Eur Heart J Open
. 2023 Jan;
2(6):oeac079.
PMID: 36600884
Aims: The aim of this study was to evaluate the effect of the intervention by proactively sharing a patient's high polygenic risk score (PRS) for coronary artery disease (CAD). Outcomes...
8.
Banach M, Reiner Z, Cicero A, Sabouret P, Viigimaa M, Sahebkar A, et al.
Arch Med Sci
. 2022 Dec;
18(6):1429-1434.
PMID: 36457968
No abstract available.
9.
Parm U, Tamm A, Laugamets A, Viigimaa M
Medicina (Kaunas)
. 2021 Dec;
57(12).
PMID: 34946292
Physical activity has a positive impact on health, and the participation in exercise and sports, including marathons, has increased in popularity. This kind of sport requires extreme endurance, which can...
10.
Alev K, Kutt A, Viigimaa M
Front Digit Health
. 2021 Oct;
2:567656.
PMID: 34713041
The integration of genetic testing into eHealth applications holds great promise for the personalization of disease prevention guidelines. However, relatively little is known about the impact of eHealth applications on...